Physician
Farukhi, Shahzad
Farukhi, Shahzad was paid $1.43M by Medicaid between Feb 2018 and Oct 2023, across 16 billing codes. Its largest line is U0002, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc — 44% of everything it billed.
33Billing provider infoFARUKHI, SHAHZAD
KETTERING, OH 45429
KETTERING, OH 45429
33aNPI1316197296assigned 09/26/2008
33bProvider typeInternal Medicine Physician
28Total paid$1.43M
24GClaims47,144
24DCodes billed16
24AFirst – last monthFeb 2018 – Oct 2023
Compared with peers
Next to other Internal Medicine Physician providers in Ohio
Rank by total paid#34 of 663
Median peer was paid$17K
This provider vs. median82×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,173 | $92K | |
| 2019 | 244 | $9K | |
| 2021 | 122 | $3K | |
| 2022 | 33,151 | $964K | |
| 2023 | 11,454 | $360K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 44% | 12,936 | 6,104 | $623K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 27% | 11,693 | 5,927 | $384K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 16% | 11,293 | 4,360 | $230K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 6.1% | 2,164 | 288 | $88K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 4.0% | 5,108 | 2,777 | $58K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 959 | 520 | $19K |
| 99223 | Prolong inpt eval add15 m | <1% | 130 | 125 | $9K |
| 99000 | <1% | 1,288 | 613 | $4K | |
| 99358 | Prolong nursin fac eval 15m | <1% | 88 | 88 | $4K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 1,010 | 432 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 250 | 81 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 32 | 17 | $2K |
4 more codes
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 69 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 61 | $765.00 |
| 99406 | <1% | 35 | $337.79 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 28 | $51.31 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.